CircCDK14 ameliorates interleukin-1β-induced chondrocyte damage by the miR-1183/KLF5 pathway in osteoarthritis

The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism. Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1...

Full description

Saved in:
Bibliographic Details
Published inAutoimmunity (Chur, Switzerland) Vol. 55; no. 6; pp. 408 - 417
Main Authors Lai, Xiaowei, Song, Yali, Tian, Jimei
Format Journal Article
LanguageEnglish
Published Taylor & Francis 18.08.2022
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism. Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis. CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA. CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA.
AbstractList The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism. Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis. CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA. CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA.
Background The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism. Methods Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis. Results CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA. Conclusion CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA.
The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism.BACKGROUNDThe pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism.Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis.METHODSHuman chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis.CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA.RESULTSCircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA.CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA.CONCLUSIONCircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA.
Author Lai, Xiaowei
Tian, Jimei
Song, Yali
Author_xml – sequence: 1
  givenname: Xiaowei
  surname: Lai
  fullname: Lai, Xiaowei
  organization: Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College
– sequence: 2
  givenname: Yali
  surname: Song
  fullname: Song, Yali
  organization: Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College
– sequence: 3
  givenname: Jimei
  surname: Tian
  fullname: Tian, Jimei
  organization: Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College
BookMark eNqFkc9qFEEQxgeJ4Cb6CMIcvUzSPf0fL8pqNGRBEAVvTU1PTbbjTPfa3UuY1_JBfCZnszEHD3qpguL7flXFd1qdhBiwql5Sck6JJhdEGyoN4-ctadulaKo5e1KtqCSq0bz9dlKtDprmIHpWneZ8SwhpleSrKq59cut315TXMOHoY4KCufahYBpx_92Hhv762fjQ7x32tdvG0Kfo5oJ1DxPcYN3NddliPfnPDaWaXVxvLkW9g7K9g3nh1DEXjJDKNvni8_Pq6QBjxhcP_az6evn-y_pjs_n04Wr9dtM4xkxpFJHKIHYEpWO87wzpGTAhKVcD09Bx0knXakE6LpxkmmkDwhC-PK8p5R07q66O3D7Crd0lP0GabQRv7wcx3djlJu9GtB0z2AsjCAjNUfUGlASFWiqhpBZ0Yb06snYp_thjLnby2eE4QsC4z7aVSitmWioWqThKXYo5JxweV1NiD2HZP2HZQ1j2IazF9_ovn_MFio-hJPDjf91vjm4fhpgmuItp7G2BeYxpSBCcz5b9G_EbB2-tww
CitedBy_id crossref_primary_10_1016_j_heliyon_2023_e13152
crossref_primary_10_1007_s00018_024_05460_4
crossref_primary_10_3390_biom13111606
crossref_primary_10_1111_os_13848
crossref_primary_10_3390_ijms232315174
crossref_primary_10_1002_mco2_723
crossref_primary_10_1038_s41598_023_29561_5
crossref_primary_10_1016_j_bcp_2023_115580
crossref_primary_10_3389_fgene_2023_1173812
Cites_doi 10.1080/15384101.2020.1772545
10.1186/gb-2003-4-2-206
10.1042/BSR20201573
10.1002/jcp.27384
10.1038/nsmb.2959
10.1016/j.joca.2016.12.024
10.1038/nrrheum.2011.109
10.1016/j.ymthe.2019.01.006
10.1002/cbin.10761
10.1111/jcmm.14400
10.1016/j.yjmcc.2014.11.023
10.1016/j.prp.2011.09.015
10.1042/BSR20191523
10.1136/annrheumdis-2018-214786
10.1186/ar4133
10.1093/jb/mvaa119
10.2174/1566523219666190716092203
10.1016/j.cell.2009.01.002
10.1016/j.bbrc.2018.11.157
10.1016/j.bbrc.2018.02.036
10.1007/978-981-10-1498-7_7
10.3390/cells7080092
10.5312/wjo.v6.i1.95
10.1001/jama.2018.19319
10.1159/000055915
10.3892/mmr.2016.5419
10.1016/j.bone.2005.08.007
10.1136/annrheumdis-2013-204308
10.1074/jbc.M709857200
10.1016/j.omtn.2020.07.039
10.7150/thno.45993
10.18632/aging.102160
10.1016/S0021-9258(18)61450-4
10.1016/j.intimp.2021.107704
10.1080/21505594.2020.1735051
10.1016/j.bbadis.2019.06.010
10.1016/j.omtn.2019.02.005
ContentType Journal Article
Copyright 2022 Informa UK Limited, trading as Taylor & Francis Group 2022
Copyright_xml – notice: 2022 Informa UK Limited, trading as Taylor & Francis Group 2022
DBID AAYXX
CITATION
7X8
DOA
DOI 10.1080/08916934.2022.2081843
DatabaseName CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1607-842X
EndPage 417
ExternalDocumentID oai_doaj_org_article_b39ed5950a584e7d9a76a7e867576851
10_1080_08916934_2022_2081843
2081843
Genre Research Article
GroupedDBID ---
00X
03L
0BK
0YH
23N
36B
4.4
5GY
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AFKVX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
CITATION
7X8
GROUPED_DOAJ
ID FETCH-LOGICAL-c339t-70679eeb0e6c34db90d3a356147f38ab40b6c2850b45c638389a59042088114b3
IEDL.DBID DOA
ISSN 0891-6934
1607-842X
IngestDate Wed Aug 27 01:28:10 EDT 2025
Fri Jul 11 08:39:35 EDT 2025
Thu Apr 24 22:56:35 EDT 2025
Tue Jul 01 03:37:39 EDT 2025
Wed Dec 25 09:05:50 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c339t-70679eeb0e6c34db90d3a356147f38ab40b6c2850b45c638389a59042088114b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/b39ed5950a584e7d9a76a7e867576851
PQID 2678739215
PQPubID 23479
PageCount 10
ParticipantIDs crossref_primary_10_1080_08916934_2022_2081843
crossref_citationtrail_10_1080_08916934_2022_2081843
doaj_primary_oai_doaj_org_article_b39ed5950a584e7d9a76a7e867576851
informaworld_taylorfrancis_310_1080_08916934_2022_2081843
proquest_miscellaneous_2678739215
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-18
PublicationDateYYYYMMDD 2022-08-18
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-18
  day: 18
PublicationDecade 2020
PublicationTitle Autoimmunity (Chur, Switzerland)
PublicationYear 2022
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References CIT0030
CIT0010
CIT0032
CIT0031
CIT0012
CIT0034
CIT0033
CIT0014
CIT0036
CIT0035
CIT0016
CIT0038
CIT0015
CIT0037
CIT0018
CIT0017
CIT0039
CIT0019
Wu Q (CIT0013) 2020; 24
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
Yuan S (CIT0011) 2019; 39
CIT0003
CIT0025
CIT0002
CIT0024
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0029
CIT0006
CIT0028
CIT0009
CIT0008
References_xml – ident: CIT0025
  doi: 10.1080/15384101.2020.1772545
– ident: CIT0033
  doi: 10.1186/gb-2003-4-2-206
– ident: CIT0031
  doi: 10.1042/BSR20201573
– ident: CIT0010
  doi: 10.1002/jcp.27384
– ident: CIT0008
  doi: 10.1038/nsmb.2959
– ident: CIT0038
  doi: 10.1016/j.joca.2016.12.024
– ident: CIT0004
  doi: 10.1038/nrrheum.2011.109
– ident: CIT0018
  doi: 10.1016/j.ymthe.2019.01.006
– ident: CIT0026
  doi: 10.1002/cbin.10761
– ident: CIT0014
  doi: 10.1111/jcmm.14400
– ident: CIT0032
  doi: 10.1016/j.yjmcc.2014.11.023
– ident: CIT0035
  doi: 10.1016/j.prp.2011.09.015
– ident: CIT0020
  doi: 10.1042/BSR20191523
– volume: 39
  start-page: 1312
  year: 2019
  ident: CIT0011
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
– ident: CIT0017
  doi: 10.1136/annrheumdis-2018-214786
– ident: CIT0027
  doi: 10.1186/ar4133
– ident: CIT0012
  doi: 10.1093/jb/mvaa119
– ident: CIT0005
  doi: 10.2174/1566523219666190716092203
– ident: CIT0015
  doi: 10.1016/j.cell.2009.01.002
– ident: CIT0030
  doi: 10.1016/j.bbrc.2018.11.157
– ident: CIT0006
  doi: 10.1016/j.bbrc.2018.02.036
– ident: CIT0007
  doi: 10.1007/978-981-10-1498-7_7
– ident: CIT0016
  doi: 10.3390/cells7080092
– ident: CIT0024
  doi: 10.5312/wjo.v6.i1.95
– ident: CIT0003
  doi: 10.1001/jama.2018.19319
– ident: CIT0023
  doi: 10.1159/000055915
– ident: CIT0028
  doi: 10.3892/mmr.2016.5419
– ident: CIT0001
  doi: 10.1016/j.bone.2005.08.007
– ident: CIT0002
  doi: 10.1136/annrheumdis-2013-204308
– ident: CIT0034
  doi: 10.1074/jbc.M709857200
– ident: CIT0039
  doi: 10.1016/j.omtn.2020.07.039
– ident: CIT0029
  doi: 10.7150/thno.45993
– ident: CIT0019
  doi: 10.18632/aging.102160
– ident: CIT0022
  doi: 10.1016/S0021-9258(18)61450-4
– ident: CIT0037
  doi: 10.1016/j.intimp.2021.107704
– ident: CIT0021
  doi: 10.1080/21505594.2020.1735051
– ident: CIT0036
  doi: 10.1016/j.bbadis.2019.06.010
– ident: CIT0009
  doi: 10.1016/j.omtn.2019.02.005
– volume: 24
  start-page: 7937
  issue: 15
  year: 2020
  ident: CIT0013
  publication-title: Eur Rev Med Pharmacol Sci
SSID ssj0002764
Score 2.37666
Snippet The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin...
Background The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA...
SourceID doaj
proquest
crossref
informaworld
SourceType Open Website
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 408
SubjectTerms circCDK14
exosomes
KLF5
miR-1183
Title CircCDK14 ameliorates interleukin-1β-induced chondrocyte damage by the miR-1183/KLF5 pathway in osteoarthritis
URI https://www.tandfonline.com/doi/abs/10.1080/08916934.2022.2081843
https://www.proquest.com/docview/2678739215
https://doaj.org/article/b39ed5950a584e7d9a76a7e867576851
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTttAEF5VoCIuqKRFpBS0lbhuY3u9tvdIQiNESA-oSLmt9s8iInFQ6gjltXgQnokZ_0SUHnLpdeW1VzuzM9_Mer4h5NyBk3PcC2Zd5lgcal8lmpjMHVhDB2ZZY4Hz-FdydRdfT8TkTasv_CespgeuN65nuPROSBFocJU-dVKniU59BkAXkHJVPB2Bz2uDqcYGR2lNHJXJkCWSx23tDrJqwxgOQWwYYSVWhh1P_vJKFXn_O-rSf0x15X-Gn8hBAxzpRb3gQ_LBFx3ysW4lue6QvXFzSf6ZLAbTpR1cjsKY6rmfYQ0-4EmKxBDLmV89TAsWvjwzCMZBrI6C_UPSArsuPXV6DvaFmjUFXEjn01sGkQHvjW6GgmLv4ie9hvdQLAxZwNbdV4xIX8jd8OfvwRVr-iowy7ksWYrJI-9N4BPLY2dk4LjmSAma5jzTJg5MYqNMBCYWFs4nYBotZIAX8RmET4YfkZ1iUfhjQq0MbMRFHkkEXrnRAgJOAA1G-zwHJNIlcbuvyjak49j7YqbClpu0EYdCcahGHF3yYzPtsWbd2Dahj0LbPIyk2dUAqJJqVEltU6UukW9FrsoqZ5LXDU4U37KA761-KDigeOuiC79Y_VERwIEUUGgovv6PRZ6QffwuprXD7BvZKZcrfwq4qDRnZPeif9kfnlVH4RVd6AJW
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CircCDK14+ameliorates+interleukin-1%CE%B2-induced+chondrocyte+damage+by+the+miR-1183%2FKLF5+pathway+in+osteoarthritis&rft.jtitle=Autoimmunity+%28Chur%2C+Switzerland%29&rft.au=Xiaowei+Lai&rft.au=Yali+Song&rft.au=Jimei+Tian&rft.date=2022-08-18&rft.pub=Taylor+%26+Francis+Group&rft.issn=0891-6934&rft.eissn=1607-842X&rft.volume=55&rft.issue=6&rft.spage=408&rft.epage=417&rft_id=info:doi/10.1080%2F08916934.2022.2081843&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b39ed5950a584e7d9a76a7e867576851
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0891-6934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0891-6934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0891-6934&client=summon